<DOC>
	<DOCNO>NCT01910506</DOCNO>
	<brief_summary>This study determine characteristic absorption , metabolism , excretion ( AME ) RDEA3170 follow single 10 mg dose RDEA3170 oral solution 500 microcuries ( µCi ) [ 14 C ] RDEA3170 healthy adult male subject .</brief_summary>
	<brief_title>RDEA3170 AME Study</brief_title>
	<detailed_description />
	<criteria>Body weight ≥ 50 kg ( 110 lb . ) body mass index ≥ 18 ≤ 30 kg/m2 . No clinically relevant abnormality vital sign , ECG , physical examination safety laboratory value . Screening serum urate level ≤ 7.0 mg/dL . Subject minimum 1 bowel movement day . History suspicion kidney stone . History gastrointestinal ulcer , Helicobacter pylorus infection , disorder gastric pH . History previous surgery stomach small intestine ( appendectomy acceptable ) . Subject donate blood experienced significant blood loss ( &gt; 450 mL ) within 12 week prior Day 1 give plasma donation within 6 week prior Day 1 . Inadequate venous access unsuitable vein repeat venipuncture .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>